Arkolith/Insider Trading/COAG/Form 4

Novo Holdings A/S

10% OwnerHemab Therapeutics Holdings, Inc. (COAG) · full profile →Form 4 · filed May 6, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 4, 2026Conversion(C)4.2M——4.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 4, 2026Conversion(C)23K—$00
May 4, 2026Conversion(C)72K—$00
May 4, 2026Conversion(C)62K—$00
May 4, 2026Conversion(C)33K—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001388325-26-000023) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML